Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IMARA Inc. | Director | Common Stock | 2.34M | $35.5M | $15.14 | Jun 2, 2022 | By entities affiliated with Arix Bioscience plc |
Iterum Therapeutics plc | Director | Ordinary Shares | 18.3K | $25.6K | $1.40 | Jun 15, 2023 | Direct |
Harpoon Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $23.00 | Mar 11, 2024 | Direct |
Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 12, 2024 | Direct | ||
IMARA Inc. | Director | Stock Options (Right to Buy) | 8.5K | Jun 2, 2022 | Direct | ||
Harpoon Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 0 | Mar 11, 2024 | Direct | ||
Iterum Therapeutics plc | Director | Restricted Share Units | 0 | Jun 15, 2023 | Direct | ||
Pyxis Oncology, Inc. | Former Director | Common Stock | 0 | $1.40 | Apr 21, 2022 | Indirect |